Brian Ott
Neurology · Providence, RINPI 1124054101
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,441 of the $3,451 with a category attached, or 99.7%. Every reported general payment came from a single manufacturer, Biogen.
Across 3 payments — averaging $1150.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$3K
Across 92 payments — averaging $44,117 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$2.3M
- Eli Lilly$684K
- AbbVie$616K
- Eisai Inc.$428K
- Merck$39
What the payments were for
- Consulting fees$3,441100%
- Education$100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 3 | $3,451 |
How this compares
$3,451 in reported general payments places this provider in the 65th percentile of 86 neurology providers in Rhode Island.
Other neurology in Providence
- Stephen SallowayProvidence$329K
- Syed RizviProvidence$160K
- John EastonProvidence$112K
- Saima ChaudhryProvidence$90K
- Monica DhakarProvidence$45K
- Jeffrey WishikProvidence$34K
- Prathana PrakashProvidence$31K
- Karen FurieProvidence$29K
- Chuang WuProvidence$14K
- Emily WeisbachProvidence$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.